Laser, the reason I thought he was talking about Northwest Bio, is in February, Northwest stated that the PFS events had been reached and OS events should be reached in a few months. So at that time, if they were in discussions with Cryoport about commercialization preparations, it may have seemed to Cryoport that a BLA filing could happen this year. While they didn’t exactly shelve it, the trial is taking longer than it looked like it would 9 months ago, and I think Mark was doing a little ad libbing. I don’t know who else he could be talking about. I agree that we should get a readout soon, and a lot of things are lining up, (FDA guidance on RMAT’s released, funding, etc ) and it could be one of the BLA’s they are talking about for next year.
BTW - I added some more trading shares since that post, so my house could be beachfront, right next to yours. Hawaii right?
News 
Market Data 
Discover 
